Evidence map›Paper›PMID 29266204›Full record

ArticleImmunology2018

Hepatitis C virus core protein reduces CD8

Sarwat Tahsin Khan, Winston Karges, Curtis L Cooper, Angela M Crawley

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  4. [Occurrence and recurrence of hepatitis C-related hepatocellular carcinoma after direct antiviral treatment].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2022
    Review
  5. Article
  6. [Advances in liver immunology in 2018].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2019
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sarwat Tahsin KhanDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.ORCID 0000-0002-6578-8471
Winston KargesDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
Curtis L CooperSchool of Epidemiology, Public Health and Preventative Medicine, University of Ottawa, Ottawa, ON, Canada.
Angela M CrawleyDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
University of Ottawa · CA

Funding

CIHR
6 · The paper itself

Abstract

Clearance of hepatitis C virus (HCV) is dependent on an effective virus-specific CD8

Indexed as

Cell DegranulationCell ProliferationLymphocyte ActivationCD8-Positive T-LymphocytesCells, CulturedCytotoxicity, ImmunologicHepacivirusHepatitis CHost-Pathogen InteractionsHumansInterleukin-7Lysosomal-Associated Membrane Protein 1Lysosomal Membrane ProteinsPerforinPhosphorylationProto-Oncogene Proteins c-bcl-2BCL2 protein, humanIL7 protein, humanInterleukin-7LAMP1 protein, humanLysosomal-Associated Membrane Protein 1Lysosomal Membrane Proteinsnucleocapsid protein, Hepatitis C virusPerforinProto-Oncogene Proteins c-bcl-2STAT5 Transcription FactorViral Core ProteinsCD8 cellcell proliferationcytotoxicitycytotoxic T-cellsviral

Identifiers

PMID29266204
PMCPMC5904700
OpenAlexW2780991151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.